Combination of thrombin and matrix metalloproteinase-9 exacerbates neurotoxicity in cell culture and intracerebral hemorrhage in mice

被引:102
作者
Xue, Mengzhou
Hollenberg, Morley D.
Yong, V. Wee
机构
[1] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada
[2] Univ Calgary, Dept Clin Neurosci, Calgary, AB T2N 4N1, Canada
[3] Univ Calgary, Dept Therapeut & Pharmacol, Calgary, AB T2N 4N1, Canada
[4] Univ Calgary, Dept Med, Calgary, AB T2N 4N1, Canada
关键词
thrombin; MMP-9; proteases; inflammation; neuronal death; ICH;
D O I
10.1523/JNEUROSCI.2806-06.2006
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The rapid loss of neurons is a major pathological outcome of intracerebral hemorrhage (ICH). Several mechanisms may produce the neurotoxicity observed in ICH, and these include proteolytic enzymes such as thrombin and matrix metalloproteinase-9 (MMP-9). We tested the hypothesis that thrombin and MMP-9 combine to injure neurons in culture and that they interact to promote the acute neurotoxicity that occurs in ICH in vivo. We report that human fetal neurons die when exposed to thrombin or MMP-9 in isolation and that a combination of these two enzymes increased neurotoxicity. The toxicity of thrombin involved protease-activated receptor-1 and the conversion of proMMP-9 to active MMP-9. In ICH, which was induced in mice by the intracerebral injection of autologous blood, significant areas of brain damage, neuronal death, microglia/macrophage activation, and neutrophil accumulation occurred by 24 h of injury. Importantly, these neuropathological features were reduced in MMP-9 null mice compared with wild-type controls, and the concordant antagonism of thrombin using hirudin also alleviated the injury found in MMP-9 null mice. Our collective results demonstrate that thrombin and MMP-9 collaborate to promote neuronal death in culture and in ICH. To improve the prognosis of ICH, the neurotoxic actions of thrombin and MMP-9 must be inhibited early and simultaneously after injury.
引用
收藏
页码:10281 / 10291
页数:11
相关论文
共 54 条
[1]   Matrix metalloproteinase-9 concentration after spontaneous intracerebral hemorrhage [J].
Abilleira, S ;
Montaner, J ;
Molina, CA ;
Monasterio, J ;
Castillo, J ;
Alvarez-Sabín, J .
JOURNAL OF NEUROSURGERY, 2003, 99 (01) :65-70
[2]   Inhibition of cellular action of thrombin by N3-cyclopropyl-7-{[4-(1-methylethyl)phenyl]methyl}-7H-pyrrolo[3,2-f]quinazoline-1,3-diamine (SCH 79797), a nonpeptide thrombin receptor antagonist [J].
Ahn, HS ;
Foster, C ;
Boykow, G ;
Stamford, A ;
Manna, M ;
Graziano, M .
BIOCHEMICAL PHARMACOLOGY, 2000, 60 (10) :1425-1434
[3]   New horizons for primary intracerebral hemorrhage treatment: experience from preclinical studies [J].
Aronowski, J ;
Hall, CE .
NEUROLOGICAL RESEARCH, 2005, 27 (03) :268-279
[4]  
BERNE RM, 1998, PHYSIOLOGY, P1232
[5]   Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke [J].
Castellanos, M ;
Leira, R ;
Serena, J ;
Pumar, JM ;
Lizasoain, I ;
Castillo, J ;
Dávalos, A .
STROKE, 2003, 34 (01) :40-45
[6]   Apoptotic, injury-induced cell death in cultured mouse murine motor neurons [J].
Citron, BA ;
Zhang, SX ;
Smirnova, IV ;
Festoff, BW .
NEUROSCIENCE LETTERS, 1997, 230 (01) :25-28
[7]   Protease-activated receptors: sentries for inflammation? [J].
Cocks, TM ;
Moffatt, JD .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (03) :103-108
[8]  
COLMAN RW, 1994, BASIC PRINCIPLES CLI
[9]   Multiple roles for MMPs and TIMPs in cerebral ischemia [J].
Cunningham, LA ;
Wetzel, M ;
Rosenberg, GA .
GLIA, 2005, 50 (04) :329-339
[10]   Plasminogen activators potentiate thrombin-induced brain injury [J].
Figueroa, BE ;
Keep, RF ;
Betz, AL ;
Hoff, JT .
STROKE, 1998, 29 (06) :1202-1207